METRO-PD1: A Phase I Feasibility Study Evaluating Anti-PD1 (NIVOLUMAB) In Combination With Metronomic Chemotherapy In Children And Teenagers With Refractory/Relapsing Solid Tumors Or Lymphoma
Presented at SIOP 2021 Congress
The Anticancer Fund is participating in the World Cancer Series organised by The Economist
Our good cause My Cancer Navigator now supported by Belfius
Drug repurposing candidates in the treatment of brain metastases
Presented during the 10th edition of Brain Metastases Research and Emerging Therapy Conference
10 drugs in 1 trial: an unconventional way to fight brain cancer
